Industry welcomes GST Council move on Covid drugs

Business Line

Urged companies to reduce the MRP on all the drugs for which GST rates have been slashed The GST Council on Friday decided to extend existing concessional GST rates on Covid-19 treatment drugs till December 31, 2021. These medicines include Amphotericin B (nil), Remdesivir (5 per cent), Tocilizumab (nil), Anti-coagulants like Heparin (5 per cent). In addition, the GST rate on seven more drugs usef…

Sign in to read the full article

Create a free account or sign in to access the complete content.